Swiss hearing loss firm to raise up to $95 million in US IPO
July 21, 2014 at 09:44 AM EDT
ZURICH, July 21 (Reuters) - Auris Medical , a Swiss company specialising in experimental hearing loss drugs, is planning a U.S. stock offering to tap into growing investor appetite for biotechnology.
